Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Caris Life Sciences (CAI) Prepaid Assets (2024 - 2025)

Caris Life Sciences has reported Prepaid Assets over the past 2 years, most recently at $2.4 million for Q4 2025.

  • Quarterly results put Prepaid Assets at $2.4 million for Q4 2025, down 64.89% from a year ago — trailing twelve months through Dec 2025 was $2.4 million (down 64.89% YoY), and the annual figure for FY2025 was $2.4 million, down 64.89%.
  • Prepaid Assets for Q4 2025 was $2.4 million at Caris Life Sciences, down from $21.2 million in the prior quarter.
  • Over the last five years, Prepaid Assets for CAI hit a ceiling of $21.2 million in Q3 2025 and a floor of $2.4 million in Q4 2025.